Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades
Abstract Background The timing of the launch of a new drug is an important factor that determines access for patients. We evaluated patient access to pharmaceuticals in 30 European markets over the past two decades. Methods Launch dates were extracted from the IQVIA (formerly IMS) database for 30 Eu...
Saved in:
Main Authors: | Melanie Büssgen (Author), Tom Stargardt (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sexual and reproductive health in Ethiopia: gains and reflections over the past two decades
by: Lisa M. DeMaria, et al.
Published: (2022) -
Oesophageal cancer in Sri Lanka: change of pattern over the past two decades
by: Mekala Fernando, et al.
Published: (2022) -
Pharmaceutical Market Access: current state of affairs and key challenges - results of the Market Access Launch Excellence Inventory (MALEI)
by: Marcus A. Koch
Published: (2015) -
Indication-wide drug pricing: Insights from the pharma market
by: Florian Siegmeier, et al.
Published: (2022) -
Reluctant Collaborators: China-Russia Co-Publications over the Past Decade
by: John P. Haupt, et al.
Published: (2023)